{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:31:29Z","timestamp":1768476689348,"version":"3.49.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18J21382"],"award-info":[{"award-number":["18J21382"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24791563"],"award-info":[{"award-number":["24791563"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10014-023-00453-w","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T07:04:18Z","timestamp":1678345458000},"page":"109-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem\/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence"],"prefix":"10.1007","volume":"40","author":[{"given":"Ryota","family":"Tamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Iwanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriel Sandika","family":"Pareira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoru","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Tsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kuranari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukina","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-1931","authenticated-orcid":false,"given":"Hikaru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"453_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00401-015-1410-7","volume":"129","author":"VP Collins","year":"2015","unstructured":"Collins VP, Jones DT, Giannini C (2015) Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol 129:775\u2013788","journal-title":"Acta Neuropathol"},{"key":"453_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/PAS.0b013e3181c75238","volume":"34","author":"FJ Rodriguez","year":"2010","unstructured":"Rodriguez FJ, Scheithauer BW, Burger PC et al (2010) Anaplasia in pilocytic astrocytoma predicts aggressive behavior. Am J Surg Pathol 34:147\u2013160","journal-title":"Am J Surg Pathol"},{"key":"453_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00401-010-0784-9","volume":"121","author":"EF Rodriguez","year":"2011","unstructured":"Rodriguez EF, Scheithauer BW, Giannini C et al (2011) PI3K\/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathol 121:407\u2013420","journal-title":"Acta Neuropathol"},{"key":"453_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10014-012-0081-5","volume":"29","author":"H Arai","year":"2012","unstructured":"Arai H, Ikota H, Sugawara K et al (2012) Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas. Brain Tumor Pathol 29:160\u2013167","journal-title":"Brain Tumor Pathol"},{"key":"453_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1097-0215(19990219)84:1<10::AID-IJC3>3.0.CO;2-L","volume":"84","author":"NO Schmidt","year":"1999","unstructured":"Schmidt NO, Westphal M, Hagel C et al (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor\/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 84:10\u201318","journal-title":"Int J Cancer"},{"key":"453_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11060-018-2876-7","volume":"139","author":"D Kamamoto","year":"2018","unstructured":"Kamamoto D, Ohara K, Kitamura Y et al (2018) Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor\/hemangiopericytoma. J Neurooncol 139:251\u2013259","journal-title":"J Neurooncol"},{"key":"453_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"453_CR8","unstructured":"WHO Classification of Tumours. Louis DN, Perry A, Wesseling P, Brat DJ, et al (2021) Central nervous system tumours. Lyon (France): International Agency for Research on Cancer. (WHO classification of tumours series, 5th ed.; vol. 6). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/45. Accessed 3 May 2022."},{"key":"453_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jocn.2017.06.059","volume":"44","author":"R Tamura","year":"2017","unstructured":"Tamura R, Miwa T, Ohira T, Yoshida K (2017) Diagnosis and treatment for pure aqueductal tumor. J Clin Neurosci 44:260\u2013263","journal-title":"J Clin Neurosci"},{"key":"453_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00701-014-2264-9","volume":"157","author":"J Roth","year":"2015","unstructured":"Roth J, Chaichana KL, Jallo G et al (2015) True aqueductal tumors: a unique entity. Acta Neurochir (Wien) 157:169\u2013177","journal-title":"Acta Neurochir (Wien)"},{"key":"453_CR11","doi-asserted-by":"publisher","first-page":"52423","DOI":"10.18632\/oncotarget.9387","volume":"7","author":"R Tamura","year":"2016","unstructured":"Tamura R, Tanaka T, Miyake K et al (2016) Histopathological investigation of glioblastomas resected under bevacizumab treatment. Oncotarget 7:52423\u201352435","journal-title":"Oncotarget"},{"key":"453_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cas.13889","volume":"110","author":"R Tamura","year":"2019","unstructured":"Tamura R, Tanaka T, Ohara K et al (2019) Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab. Cancer Sci 110:499\u2013508","journal-title":"Cancer Sci"},{"key":"453_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/bpa.12173","volume":"25","author":"H Takami","year":"2015","unstructured":"Takami H, Yoshida A, Fukushima S et al (2015) Revisiting TP53 mutations and immunohistochemistry\u2014a comparative study in 157 diffuse gliomas. Brain Pathol 25:256\u2013265","journal-title":"Brain Pathol"},{"key":"453_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1525-1578(10)60653-8","volume":"3","author":"Y Hirose","year":"2001","unstructured":"Hirose Y, Aldape K, Takahashi M et al (2001) Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diagn 3:62\u201367","journal-title":"J Mol Diagn"},{"key":"453_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0002-9440(10)61702-6","volume":"159","author":"H Sasaki","year":"2001","unstructured":"Sasaki H, Zlatescu MC, Betensky RA et al (2001) PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 159:359\u2013367","journal-title":"Am J Pathol"},{"key":"453_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405","journal-title":"Acta Neuropathol"},{"key":"453_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"},{"key":"453_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/bpa.12468","volume":"28","author":"Y Kitamura","year":"2018","unstructured":"Kitamura Y, Komori T, Shibuya M et al (2018) Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection. Brain Pathol 28:87\u201393","journal-title":"Brain Pathol"},{"key":"453_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/2152-7806.99936","volume":"3","author":"MA Khan","year":"2012","unstructured":"Khan MA, Godil SS, Tabani H et al (2012) Clinical review of pediatric pilocytic astrocytomas treated at a tertiary care hospital in Pakistan. Surg Neurol Int 3:90","journal-title":"Surg Neurol Int"},{"key":"453_CR20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/neup.12011","volume":"33","author":"Y Sugita","year":"2013","unstructured":"Sugita Y, Nakashima S, Ohshima K et al (2013) Anaplastic astrocytomas with abundant Rosenthal fibers in elderly patients: a diagnostic pitfall of high-grade gliomas. Neuropathology 33:533\u2013540","journal-title":"Neuropathology"},{"key":"453_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00381-014-2509-1","volume":"31","author":"K Saito","year":"2015","unstructured":"Saito K, Toda M, Yoshida K (2015) Pilocytic astrocytoma with anaplastic features presenting good long-term clinical course after surgery alone: a case report. Childs Nerv Syst 31:167\u2013171","journal-title":"Childs Nerv Syst"},{"key":"453_CR22","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1200\/JCO.2003.01.017","volume":"21","author":"DC Bowers","year":"2003","unstructured":"Bowers DC, Gargan L, Kapur P, Reisch JS (2003) Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol 21:2968\u20132973","journal-title":"J Clin Oncol"},{"key":"453_CR23","first-page":"295","volume":"9","author":"GP Casadei","year":"1990","unstructured":"Casadei GP, Arrigoni GL, D\u2019Angelo V, Bizzozero L (1990) Late malignant recurrence of childhood cerebellar astrocytoma. Clin Neuropathol 9:295\u2013298","journal-title":"Clin Neuropathol"},{"key":"453_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1227\/00006123-199209000-00005","volume":"31","author":"S Ito","year":"1992","unstructured":"Ito S, Hoshino T, Shibuya M et al (1992) Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling. Neurosurgery 31:413\u2013418","journal-title":"Neurosurgery"},{"key":"453_CR25","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/NEN.0000000000000015","volume":"72","author":"D Mustafa","year":"2013","unstructured":"Mustafa D, Swagemakers S, French P et al (2013) Structural and expression differences between the vasculature of pilocytic astrocytomas and glioblastomas. J Neuropathol Exp Neurol 72:1171\u20131181","journal-title":"J Neuropathol Exp Neurol"},{"key":"453_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/002215540205000203","volume":"50","author":"PM Almqvist","year":"2002","unstructured":"Almqvist PM, Mah R, Lendahl U et al (2002) Immunohistochemical detection of nestin in pediatric brain tumors. J Histochem Cytochem 50:147\u2013158","journal-title":"J Histochem Cytochem"},{"key":"453_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10014-009-0261-0","volume":"27","author":"R Kitai","year":"2010","unstructured":"Kitai R, Horita R, Sato K et al (2010) Nestin expression in astrocytic tumors delineates tumor infiltration. Brain Tumor Pathol 27:17\u201321","journal-title":"Brain Tumor Pathol"},{"key":"453_CR28","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.18632\/oncotarget.6884","volume":"7","author":"J Zeng","year":"2016","unstructured":"Zeng J, Zhang XK, Chen HD et al (2016) Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas. Oncotarget 7:8944\u20138955","journal-title":"Oncotarget"},{"key":"453_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/2011.4.JNS101172","volume":"115","author":"I Yang","year":"2011","unstructured":"Yang I, Han SJ, Sughrue ME et al (2011) Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg 115:505\u2013511","journal-title":"J Neurosurg"},{"key":"453_CR30","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s13277-013-1376-9","volume":"35","author":"B Wei","year":"2014","unstructured":"Wei B, Wang L, Zhao X et al (2014) The upregulation of programmed death 1 on peripheral blood T cells of glioma is correlated with disease progression. Tumour Biol 35:2923\u20132929","journal-title":"Tumour Biol"},{"key":"453_CR31","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1158\/1078-0432.CCR-11-0034","volume":"17","author":"C Hawkins","year":"2011","unstructured":"Hawkins C, Walker E, Mohamed N et al (2011) BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res 17:4790\u20134798","journal-title":"Clin Cancer Res"},{"key":"453_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-009-0634-9","volume":"119","author":"C Horbinski","year":"2010","unstructured":"Horbinski C, Hamilton RL, Nikiforov Y, Pollack IF (2010) Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol 119:641\u2013649","journal-title":"Acta Neuropathol"},{"key":"453_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/PAS.0b013e3182329480","volume":"36","author":"T Tihan","year":"2012","unstructured":"Tihan T, Ersen A, Qaddoumi I et al (2012) Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study. Am J Surg Pathol 36:43\u201355","journal-title":"Am J Surg Pathol"},{"key":"453_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/path.2558","volume":"218","author":"T Forshew","year":"2009","unstructured":"Forshew T, Tatevossian RG, Lawson AR et al (2009) Activation of the ERK\/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 218:172\u2013181","journal-title":"J Pathol"},{"key":"453_CR35","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1054\/bjoc.1999.1066","volume":"82","author":"D Sanoudou","year":"2010","unstructured":"Sanoudou D, Tingby O, Ferguson-Smith MA et al (2010) Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer 82:1218\u20131222","journal-title":"Br J Cancer"},{"key":"453_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/jnen\/nlw001","volume":"75","author":"JJ Roth","year":"2016","unstructured":"Roth JJ, Fierst TM, Waanders AJ et al (2016) Whole chromosome 7 gain predicts higher risk of recurrence in pediatric pilocytic astrocytomas independently from KIAA1549-BRAF fusion status. J Neuropathol Exp Neurol 75:306\u2013315","journal-title":"J Neuropathol Exp Neurol"},{"key":"453_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-4608(01)00483-6","volume":"131","author":"P Roberts","year":"2001","unstructured":"Roberts P, Chumas PD, Picton S et al (2001) Review of the cytogenetics of 58 pediatric brain tumors. Cancer Genet Cytogenet 131:1\u201312","journal-title":"Cancer Genet Cytogenet"},{"key":"453_CR38","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1054\/bjoc.1999.1066","volume":"82","author":"D Sanoudou","year":"2000","unstructured":"Sanoudou D, Tingby O, Ferguson-Smith MA et al (2000) Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer 82:1218\u20131222","journal-title":"Br J Cancer"},{"key":"453_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/gcc.1192","volume":"32","author":"S Alvarez","year":"2001","unstructured":"Alvarez S, MacGrogan D, Calasanz MJ et al (2001) Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization. Genes Chromosomes Cancer 32:285\u2013293","journal-title":"Genes Chromosomes Cancer"},{"key":"453_CR40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/gcc.20767","volume":"49","author":"R Kuuselo","year":"2010","unstructured":"Kuuselo R, Simon R, Karhu R et al (2010) 19q13 amplification is associated with high grade and stage in pancreatic cancer. Genes Chromosomes Cancer 49:569\u2013575","journal-title":"Genes Chromosomes Cancer"},{"key":"453_CR41","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/carcin\/20.11.2083","volume":"20","author":"K Ogawa","year":"1999","unstructured":"Ogawa K, Osanai M, Obata M et al (1999) Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosomes 4 and 12 is detected only in the cell lines. Carcinogenesis 20:2083\u20132088","journal-title":"Carcinogenesis"},{"key":"453_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10555-015-9571-3","volume":"34","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang Y, Nilsson CL et al (2015) Erratum to: association of chromosome 19 to lung cancer genotypes and phenotypes. Cancer Metastasis Rev 34:227","journal-title":"Cancer Metastasis Rev"},{"key":"453_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1046\/j.1365-2559.1998.00503.x","volume":"33","author":"T Matsumoto","year":"1998","unstructured":"Matsumoto T, Fujii T, Yabe M et al (1998) MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults. Histopathology 33:446\u2013452","journal-title":"Histopathology"},{"key":"453_CR44","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jocn.2009.04.012","volume":"16","author":"A Azad","year":"2009","unstructured":"Azad A, Deb S, Cher L (2009) Primary anaplastic pilocytic astrocytoma. J Clin Neurosci 16:1704\u20131706","journal-title":"J Clin Neurosci"},{"key":"453_CR45","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a002378","volume":"4","author":"LY Ballester","year":"2018","unstructured":"Ballester LY, Penas-Prado M, Leeds NE et al (2018) FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia. Cold Spring Harb Mol Case Stud 4:a002378","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"453_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clineuro.2016.06.005","volume":"147","author":"M Fiechter","year":"2016","unstructured":"Fiechter M, Hewer E, Knecht U et al (2016) Adult anaplastic pilocytic astrocytoma \u2013 a diagnostic challenge? A case series and literature review. Clin Neurol Neurosurg 147:98\u2013104","journal-title":"Clin Neurol Neurosurg"},{"key":"453_CR47","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1212\/WNL.0000000000004575","volume":"89","author":"S Hayashi","year":"2017","unstructured":"Hayashi S, Akao N, Nakazato Y (2017) Pilocytic astrocytoma with anaplasia arising from the optic chiasm in a very elderly patient. Neurology 89:1840","journal-title":"Neurology"},{"key":"453_CR48","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.clineuro.2012.01.034","volume":"114","author":"MS Hsieh","year":"2012","unstructured":"Hsieh MS, Ho JT, Lin LW et al (2012) Cerebellar anaplastic pilocytic astrocytoma in a patient of neurofibromatosis type-1: case report and review of the literature. Clin Neurol Neurosurg 114:1027\u20131029","journal-title":"Clin Neurol Neurosurg"},{"key":"453_CR49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<797::AID-IJC5>3.0.CO;2-T","volume":"76","author":"N Ishii","year":"1998","unstructured":"Ishii N, Sawamura Y, Tada M et al (1998) Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay. Int J Cancer 76:797\u2013800","journal-title":"Int J Cancer"},{"key":"453_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s004150070175","volume":"247","author":"JA Kraus","year":"2000","unstructured":"Kraus JA, Wenghoefer M, Schmidt MC et al (2000) Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J Neurol 247:455\u2013460","journal-title":"J Neurol"},{"key":"453_CR51","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/0268869031000153152","volume":"17","author":"B Lach","year":"2003","unstructured":"Lach B, Al Shail E, Patay Z (2003) Spontaneous anaplasia in pilocytic astrocytoma of cerebellum. Br J Neurosurg 17:250\u2013252","journal-title":"Br J Neurosurg"},{"key":"453_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2176\/nmc.51.144","volume":"51","author":"I Shibahara","year":"2011","unstructured":"Shibahara I, Kawaguchi T, Kanamori M et al (2011) Pilocytic astrocytoma with histological malignant features without previous radiation therapy\u2013case report. Neurol Med Chir (Tokyo) 51:144\u2013147","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"453_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/jcu.20219","volume":"34","author":"N Shinoura","year":"2006","unstructured":"Shinoura N, Takahashi M, Yamada R (2006) Delineation of brain tumor margins using intraoperative sononavigation: implications for tumor resection. J Clin Ultrasound 34:177\u2013183","journal-title":"J Clin Ultrasound"},{"key":"453_CR54","first-page":"53","volume":"15","author":"BH Srinivas","year":"2016","unstructured":"Srinivas BH, Rajesh A, Shukla D (2016) Spontaneous anaplastic transformation in cerebellar pilocytic astrocytoma: a case report and review of literature. IOSR J Dental Med Sci 15:53\u201356","journal-title":"IOSR J Dental Med Sci"},{"key":"453_CR55","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1002\/cncr.23148","volume":"110","author":"C Stuer","year":"2007","unstructured":"Stuer C, Vilz B, Majores M et al (2007) Frequent recurrence and progression in pilocytic astrocytoma in adults. Cancer 110:2799\u20132808","journal-title":"Cancer"},{"key":"453_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.neuchi.2015.07.002","volume":"61","author":"S Trabelsi","year":"2015","unstructured":"Trabelsi S, Mama N, Ladib M et al (2015) Adult recurrent pilocytic astrocytoma: clinical, histopathological and molecular study. Neurochirurgie 61:392\u2013397","journal-title":"Neurochirurgie"},{"key":"453_CR57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2176\/nmc.51.315","volume":"51","author":"K Tsuda","year":"2011","unstructured":"Tsuda K, Ishikawa E, Saito A et al (2011) Primary cerebellar pilocytic astrocytoma with anaplastic features in a patient with neurofibromatosis type 1 - case report -. Neurol Med Chir (Tokyo) 51:315\u2013318","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"453_CR58","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.jocn.2014.02.014","volume":"21","author":"EX Yong","year":"2014","unstructured":"Yong EX, McKelvie P, Murphy M, Wang YY (2014) Anaplastic pilocytic astrocytoma. J Clin Neurosci 21:1993\u20131996","journal-title":"J Clin Neurosci"},{"key":"453_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1750-3639.1999.tb00535.x","volume":"9","author":"VM Hayes","year":"1999","unstructured":"Hayes VM, Dirven CM, Dam A et al (1999) High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors. Brain Pathol 9:463\u2013467","journal-title":"Brain Pathol"},{"key":"453_CR60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/bpa.12336","volume":"26","author":"DA Solomon","year":"2016","unstructured":"Solomon DA, Wood MD, Tihan T et al (2016) Diffuse midline gliomas with histone H3\u2013K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26:569\u2013580","journal-title":"Brain Pathol"},{"key":"453_CR61","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425\u2013437","journal-title":"Cancer Cell"},{"key":"453_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1309\/AJCPABOHBC33FVMO","volume":"139","author":"GH Gielen","year":"2013","unstructured":"Gielen GH, Gessi M, Hammes J (2013) H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. Am J Clin Pathol 139:345\u2013349","journal-title":"Am J Clin Pathol"},{"key":"453_CR63","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231","journal-title":"Nature"},{"key":"453_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253","journal-title":"Nat Genet"},{"key":"453_CR65","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ng.2611","volume":"45","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wu G, Miller CP et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric lowgrade gliomas. Nat Genet 45:602\u2013612","journal-title":"Nat Genet"},{"key":"453_CR66","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/acn3.184","volume":"2","author":"A Hochart","year":"2015","unstructured":"Hochart A, Escande F, Rocourt N et al (2015) Long survival in a child with a mutated K27M\u2013H3.3 pilocytic astrocytoma. Ann Clin Transl Neurol 2:439\u2013443","journal-title":"Ann Clin Transl Neurol"},{"key":"453_CR67","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3171\/2017.4.JNS162443","volume":"129","author":"S Morita","year":"2018","unstructured":"Morita S, Nitta M, Muragaki Y et al (2018) Brainstem pilocytic astrocytoma with H3 K27M mutation: case report. J Neurosurg 129:593\u2013597","journal-title":"J Neurosurg"},{"key":"453_CR68","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40478-016-0361-0","volume":"4","author":"C Orillac","year":"2016","unstructured":"Orillac C, Thomas C, Dastagirzada Y et al (2016) Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation. Acta Neuropathol Commun 4:84","journal-title":"Acta Neuropathol Commun"},{"key":"453_CR69","first-page":"30015","volume":"S1878\u20138750","author":"TY El Ahmadieh","year":"2019","unstructured":"El Ahmadieh TY, Plitt A, Kafka B et al (2019) H3 K27M mutations in thalamic pilocytic astrocytomas with anaplasia. World Neurosurg S1878\u20138750:30015\u201330014","journal-title":"World Neurosurg"},{"key":"453_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/bpa.12646","volume":"29","author":"FJ Rodriguez","year":"2019","unstructured":"Rodriguez FJ, Brosnan-Cashman JA, Allen SJ et al (2019) Alternative lengthening of telomeres, ATRX loss and H3\u2013K27M mutations in histologically defined pilocytic astrocytoma with anaplasia. Brain Pathol 29:126\u2013140","journal-title":"Brain Pathol"},{"key":"453_CR71","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00432-018-02836-5","volume":"4","author":"A Ebrahimi","year":"2019","unstructured":"Ebrahimi A, Skardelly M, Schuhmann MU et al (2019) High frequency of H3 K27M mutations in adult midline gliomas. J Cancer Res Clin Oncol 4:839\u2013850","journal-title":"J Cancer Res Clin Oncol"},{"key":"453_CR72","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5414\/NP300990","volume":"36","author":"S Reers","year":"2017","unstructured":"Reers S, Krug D, Stummer W, Hasselblatt M (2017) Malignant progression of a histone H3.3 K27M-mutated spinal pilocytic astrocytoma in an adult. Clin Neuropathol 36:83\u201385","journal-title":"Clin Neuropathol"},{"key":"453_CR73","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","volume":"135","author":"DN Louis","year":"2018","unstructured":"Louis DN, Giannini C, Capper D et al (2018) cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135:639\u2013642","journal-title":"Acta Neuropathol"},{"key":"453_CR74","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00401-018-1805-3","volume":"135","author":"D Pratt","year":"2018","unstructured":"Pratt D, Natarajan SK, Banda A et al (2018) Circumscribed\/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas. Acta Neuropathol 135:299\u2013301","journal-title":"Acta Neuropathol"},{"key":"453_CR75","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/neuonc\/nos309","volume":"15","author":"MH Fakhreddine","year":"2013","unstructured":"Fakhreddine MH, Mahajan A, Penas-Prado M et al (2013) Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol 15:406\u2013412","journal-title":"Neuro Oncol"},{"key":"453_CR76","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-018-1837-8","volume":"136","author":"A Reinhardt","year":"2018","unstructured":"Reinhardt A, Stichel D, Schrimpf D et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A\/B and ATRX alterations. Acta Neuropathol 136:273\u2013291","journal-title":"Acta Neuropathol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-023-00453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-023-00453-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-023-00453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:35:46Z","timestamp":1702049746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-023-00453-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s10014-023-00453-w","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.N. declared consultancy role with K\u2010Pharma Inc. and research funding from RMic and Hisamitsu. H.O. declared a compensated scientific consultancy role for San Bio Co. Ltd, K Pharma Inc and RMic. The other authors declared no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}